Markets:

Overview

News

Currencies

International

Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.303 +0.003 (+0.24%)

Streaming Delayed Price Updated: 10:42 AM EDT, Jun 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Bionano Genomics, Inc (BNGO) Q2 2021 Earnings Call Transcript ↗

August 05, 2021

BNGO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Bionano’s Technology Is Interesting, But Its Earnings Are Uninspiring ↗

August 02, 2021

Bionano could become a decent testing company within its niche. However, BNGO stock has run far ahead of the company's fundamentals.

Via InvestorPlace

AMC Entertainment Tops Q2 Trends For Millenials And Gen Z, WISH Enters The Top 100 ↗

July 26, 2021

A quarterly report from Apex Clearing shows what the top owned stocks are among Millenials and Gen Z. Here is a look at the top holdings and the biggest movers from the first...

Via Benzinga

Weak Fundamentals Prove There Is No Reason to Buy Bionano Genomics ↗

July 23, 2021

Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.

Via InvestorPlace

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

You’d Be Wrong to Paint Bionano Genomics Stock With the Meme-Stock Brush ↗

July 16, 2021

With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip.

Via InvestorPlace

Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week ↗

July 16, 2021

The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.

Via The Motley Fool

Unusual Options Activity Insight: Bionano Genomics ↗

July 09, 2021

Bionano Genomics (NASDAQ:BNGO) shares experienced unusual options activity on Friday. The stock price moved up to $6.71 following the option alert. Sentiment: BULLISH Option...

Via Benzinga

Cramer Gives His Opinion On RadNet, Nano Dimension And More ↗

July 07, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said RadNet Inc. (NASDAQ: RDNT) is a great situation and he likes the stock. BioNano Genomics Inc (NASDAQ: BNGO) is...

Via Benzinga

Understanding Bionano Genomics's Unusual Options Activity ↗

July 01, 2021

Shares of Bionano Genomics (NASDAQ:BNGO) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $7.05. Sentiment:...

Via Benzinga

Bionano Genomics Stock Has Short-Term Opportunities ↗

June 28, 2021

BNGO stock has established a reliable trading range. Even long-term investors can game it while they wait for their long-term reward.

Via InvestorPlace

BNGO Stock: 2 Big Reasons Bionano Genomics Fans Should Be Cheering ↗

June 28, 2021

Bionano Genomics (BNGO) stock is getting a boost on Monday from a couple of new pieces of news that traders will want to know.

Via InvestorPlace

44 Stocks Moving In Monday's Mid-Day Session ↗

June 28, 2021

Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software...

Via Benzinga

Wait for the Reddit Set to Sell Before Buying Bionano Stock ↗

June 28, 2021

Genomics play BNGO stock may pay off down the road, but wait for a meme stock investor exodus before making it a buy

Via InvestorPlace

Why Bionano Genomics Stock Is Trading Higher Today ↗

June 28, 2021

BioNano Genomics Inc (NASDAQ: BNGO) shares are trading higher by 3.7% at $7.80 Monday morning after the company announced that it was added as a member of the U.S. small...

Via Benzinga

Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks ↗

June 28, 2021

Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics.

Via InvestorPlace

Don’t Wait Around for a Short Squeeze on Bionano Genomics Stock ↗

June 28, 2021

There are viable short-squeeze arguments available but BNGO stock is probably not one of them.

Via InvestorPlace

Geographic Expansion Enables Healthy Diagnosis for Bionano Genomics ↗

June 25, 2021

BNGO stock has a clear shot at revisiting its all-time high price

Via InvestorPlace

The Owners of Bionano Stock Will Be Hurt by Dilution ↗

June 22, 2021

BNGO stock looks decent until you dive deeper and understand what's really going on. The shares' outlook isn't good.

Via InvestorPlace

Bionano Genomics: Did Reddit Squirrels Find a Nut? ↗

June 22, 2021

BNGO stock has been pushed this year by both Wall Street pros and meme stock amateurs. Its optical genetic sequencing technique could make it a winner.

Via InvestorPlace

Analyst Says Bionano Genomics Has 26% Upside: Should You Buy? ↗

June 21, 2021

Before you buy some BNGO stock, you might want to check out some of the competition

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021 ↗

June 16, 2021

Upgrades According to Piper Sandler, the prior rating for First Bancorp (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 08, 2021

Gainers Aytu BioPharma (NASDAQ:AYTU) stock increased by 19.36% to $6.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $161.3...

Via Benzinga

Is It Too Late to Buy BioNano Genomics Stock? ↗

June 08, 2021

Does this gene-testing biotech company have value as more than a short-squeeze play?

Via The Motley Fool

60 Biggest Movers From Yesterday ↗

June 08, 2021

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle...

Via Benzinga

Why Bionano Genomics Stock Soared Today ↗

June 07, 2021

The genetic testing specialist is bolstering its leadership ranks.

Via The Motley Fool

Dow, S&P Erase Gains at Midday Despite Strong Start ↗

June 07, 2021

The Dow Jones Industrial Average is down roughly 124 points at midday, erasing this morning's gains despite nearing a fresh intraday high earlier in the session.

Via Talk Markets

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 07, 2021

Gainers Atossa Therapeutics (NASDAQ:ATOS)...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

June 07, 2021

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) surged 60.3% to $5.93 after the company...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.